Tandym Group Acquires Entitech Solutions, Bringing Enhanced Healthcare and Life Sciences Integration Capabilities to The Tandym Catalyst™ Platform

NEW YORK, July 9, 2025 /PRNewswire/ -- Tandym Group, the leader in specialized solutions for the healthcare, life sciences, technology and professional services industries, today announced its acquisition of Entitech Solutions, a leading provider of tailored solutions for healthcare and life sciences organizations.

"We are excited to welcome the talented team at Entitech Solutions to the Tandym family," said Byrne Mulrooney, CEO of Tandym Group. "Acquiring Entitech aligns with our vision to broaden our service portfolio and extend the capabilities of Tandym Catalyst™, our AI-enabled technology platform."

The acquisition of Entitech represents Tandym's continued commitment to expanding its service portfolio to provide comprehensive workforce and technology solutions. Entitech brings specialized expertise in strategy, clinical data harmonization, and system integration services to pharmaceutical and biotech companies.

A provider of innovative technology services, Entitech helps companies meet process optimization goals at a fraction of the cost by simplifying technology and making existing systems work better. Pharmaceutical companies benefit from Entitech's ability to implement both clinical and regulatory data hubs with flexible integration architectures that connect directly to site Electronic Medical Records (EMR) systems and existing data warehouse capabilities.

"I'm thrilled about the integration of Entitech into Tandym," said Michelle Keefe, Non-Executive Director with Tandym Group. "This strategic move represents a significant step forward in our ability to deliver integrated solutions to the healthcare and life sciences industries. We're creating new opportunities for innovation and growth that I'm genuinely excited to see unfold."

Recognized globally for its deep expertise in Structured Component Authoring (SCA), Entitech built its substantial reputation leveraging SCA to deliver on upcoming regulatory requirements such as Electronic Medicinal Product Information (ePI) and Identification of Medicinal Products (IDMP). Entitech is also working with customers on how to leverage structured content as the backbone for AI/Content Generation solutions.

"Joining Tandym Group represents an exciting opportunity for our team and clients," said John Jones, CEO of Entitech Solutions. "Tandym's extensive resources and investment in the Tandym Catalyst™ platform will enable us to accelerate growth and provide greater value to healthcare and life sciences companies."

Tandym Group is backed by Mill Rock Capital, a growth and operations-oriented private investment firm, and ICG, a global alternative asset manager. Akin Gump Strauss Hauer & Feld LLP served as legal advisor to Tandym.

Contact Information  
For more information about Tandym Group, please visit https://tandymgroup.com or contact: 

David Abravanel – Director of Marketing 
[email protected] 
Tel: +1 (202) 204-5122 

About Tandym Group
Tandym Group is the leader in Specialized Talent Solutions. Our human-centered approach and AI-assisted insights work in tandem for client success. As the proven partner for mission-critical initiatives, Tandym delivers specialized solutions that require contract, permanent or project-based healthcare, technology or business professionals. Our human-centered approach means we go the extra mile to understand, anticipate and meet your most challenging workforce needs. Tandym is built on best-in-class AI to seamlessly connect candidates with ideal jobs and offer skill, labor and workforce insights.

About Entitech Solutions
Entitech Solutions is a software solutions company specializing in the life sciences and pharmaceutical industries, providing tailored technology solutions that help companies optimize processes and improve system integration. The company solves complex technology problems with simple solutions, recognizing that life science companies vary in size and operations, with unique challenges requiring customized approaches.

About Mill Rock Capital 

Mill Rock Capital is a growth and operations-oriented private investment firm that invests in well-positioned middle market industrial and business services businesses in North America. Founded by Christopher Whalen and Adi Pekmezovic, Mill Rock Capital is purpose-built to invest in family-owned businesses, owner-operators and founder-led companies across six industry verticals. Focus sectors include chemicals, materials, and packaging; industrial distribution; services; metals and engineered materials; transportation and logistics; and specialty manufacturing and industrial technology. This strategy leverages the deep expertise of the firm's principals, a majority of whom have direct operating experience in these same industries. Mill Rock Capital supports business transformation through a dual-sourcing strategy encompassing majority equity and Activ Capital^® – debt, senior equity or hybrid investments which provide business owners value-added financial partnership without relinquishing a controlling stake. For more information, please visit millrockcap.com.

About ICG 

ICG provides flexible capital solutions to help companies develop and grow. The company is a leading global alternative asset manager with over 30 years' history, managing $86.3bn of assets* and investing across the capital structure. ICG operates across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. ICG develops long-term relationships with its business partners to deliver value for shareholders, clients and employees, and uses its position of influence to benefit the environment and society. ICG is committed to being a net zero asset manager across its operations and relevant investments by 2040. ICG is a member of the FTSE 100 and listed on the London Stock Exchange (ticker symbol: ICG). Further details are available at icgam.com.

SOURCE Tandym Group